Connor, Clark & Lunn Investment Management (CC&L)’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-60,217
Closed -$898K 1548
2024
Q4
$898K Buy
+60,217
New +$981K ﹤0.01% 976
2024
Q2
Sell
-36,477
Closed -$686K 1589
2024
Q1
$686K Sell
36,477
-284,509
-89% -$4.88M ﹤0.01% 1011
2023
Q4
$4.63M Buy
320,986
+309,063
+2,592% +$4.2M 0.02% 443
2023
Q3
$207K Buy
+11,923
New +$249K ﹤0.01% 1234

Other funds holding OGN

Connor, Clark & Lunn Investment Management (CC&L)'s OGN Position: Q1 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 60,217 shares — an estimated $898K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OGN in Q3 2023 and held it in 4 quarters. The position peaked at $4.63M in Q4 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 60,217 Organon & Co shares in Q1 2025, an estimated $898K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Organon & Co in Q3 2023 and held it in 4 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Organon & Co position peaked at $4.63M in Q4 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.